Medical management of endometriosis-associated pain

被引:60
作者
Mahutte, NG [1 ]
Arici, A [1 ]
机构
[1] Yale Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, New Haven, CT 06520 USA
关键词
D O I
10.1016/S0889-8545(02)00057-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometriosis-associated pain is among the most challenging conditions in gynecologic practice. It may be found in up to 60% of women with dysmenorrhea and 40% to 50% of women with pelvic pain or dyspareunia [1]. Despite this high prevalence, diagnosis is often delayed because of the need for surgical confirmation. When treatment is initiated it often achieves only partial success. Frequently, various treatments are attempted, tolerated to varying degrees, and rejected. This cycle may result in increasing frustration felt by the patient and the physician. It is not unusual for the resulting sense of despair to sever physician-patient relationships. This need not be the case. In recent years, various new insights into the medical treatment of endometriosis-associated pain have been gained. These developments should allow most women with endometriosis to find suitable relief. It is incumbent on physicians who provide gynecologic services to women of reproductive age to be intimately familiar with these treatments and the nuances of medication delivery and combination therapy.
引用
收藏
页码:133 / +
页数:19
相关论文
共 104 条
[1]  
ADAMSON GD, 1994, INT J FERTIL MENOP S, V39, P215
[2]  
Agarwal SK, 1997, J REPROD MED, V42, P413
[3]   Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial [J].
Balasch, J ;
Creus, M ;
Fabregues, F ;
Carmona, F ;
MartinezRoman, S ;
Manau, D ;
Vanrell, JA .
HUMAN REPRODUCTION, 1997, 12 (09) :2046-2050
[4]  
BARBIERI RL, 1982, FERTIL STERIL, V37, P737
[5]   HORMONE-TREATMENT OF ENDOMETRIOSIS - THE ESTROGEN THRESHOLD HYPOTHESIS [J].
BARBIERI, RL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (02) :740-745
[6]   DANAZOL - ENDOCRINE PHARMACOLOGY AND THERAPEUTIC APPLICATIONS [J].
BARBIERI, RL ;
RYAN, KJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 141 (04) :453-463
[7]   HYPOPHYSEAL RESPONSES TO CONTINUOUS AND INTERMITTENT DELIVERY OF HYPOTHALAMIC GONADOTROPIN-RELEASING HORMONE [J].
BELCHETZ, PE ;
PLANT, TM ;
NAKAI, Y ;
KEOGH, EJ ;
KNOBIL, E .
SCIENCE, 1978, 202 (4368) :631-633
[8]   Effects of triptorelin versus placebo on the symptoms of endometriosis [J].
Bergqvist, A ;
Bergh, T ;
Hogström, L ;
Mattsson, S ;
Nordenskjöld, F ;
Rasmussen, C .
FERTILITY AND STERILITY, 1998, 69 (04) :702-708
[9]   A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis [J].
Bergqvist, A .
GYNECOLOGICAL ENDOCRINOLOGY, 2000, 14 (06) :425-432
[10]   Changes in quality of life after hormonal treatment of endometriosis [J].
Bergqvist, A ;
Theorell, T .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2001, 80 (07) :628-637